India, Sept. 10 -- Several biotech stocks were in focus Thursday, including Tenon Medical following the full repayment of its senior convertible promissory notes; AEON Biopharma after positive forced degradation study results for ABP-450; Silexion Therapeutics ahead of several September investor conferences; Orchestra BioMed following an upcoming investor conference presentation; and Indaptus Therapeutics after reporting second-quarter results and providing a corporate update.
Read on.
Tenon Medical(TNON) fully repaid its outstanding senior convertible promissory notes, with an aggregate principal balance of approximately $5.16 million, ahead of their September 11, 2026 maturity date. The repayment is expected to strengthen the company's ...